Product Images Dimethyl Fumarate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Dimethyl Fumarate NDC 43598-430 by Dr. Reddy's Laboratories Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

carton1 - carton1

carton1 - carton1

This is a prescription drug called Dimethyl Fumarate, Delayed-Release Capsules, used to treat multiple sclerosis. The usual dosage recommended is one capsule taken orally twice a day. Each capsule contains 120mg of dimethyl fumarate. The drug should be stored at a temperature between 15°C to 30°C and protected from light. The package comes with 14 capsules, and it should be dispensed in its original package. The prescription was issued in May 2020.*

carton2 - carton2

carton2 - carton2

This is a medication called Ethyl Fumarate which comes in Delayed-Release Capsules with a dosage of 240mg. Each capsule has to be swallowed whole and is recommended to take one capsule twice a day. The medication should be stored at a dry and cool place at 15°C to 30°C (59°F to 86°F) and should be protected from light. This medication is available in a package of 60 capsules and distributed by Dr. Reddy’s Laboratories Inc. The rest of the text is illegible.*

container1 - container1

container1 - container1

This is a medicine package of Dimethyl Fumarate Delayed-Release Capsules, including 18 capsules with each capsule containing 120mg of the medicine. The package includes a LOT number and EXP date of the medicine, which are necessary details to be checked before use. The packaging includes a variable coding area, and the text may be over-coded during packing.*

container2 - container2

container2 - container2

The text contains information about coding area, LOT and EXP details along with variable data. However, there is not enough information or context to provide a useful description.*

figure1 - figure1

figure1 - figure1

This appears to be a graph showing the results of a study on a medication's effectiveness in preventing disability progression related to a disease. The x-axis shows the time on the study in weeks and the y-axis shows the percentage of participants with confirmed progression of disability. The study involved a placebo group and a group taking the medication dimethyl fumarate twice daily at a dose of 240mg. The text provides details on the criteria for confirmed progression of disability.*

structure - structure

structure - structure

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.